The Overnight Low-Dose Dexamethasone Suppression Test Can Be Used to Evaluate Patients With Chronic Kidney Disease

被引：0
|
作者：
Raff, Hershel [1 ,2 ,3 ]
机构：
[1] Med Coll Wisconsin, Dept Med, Div Endocrinol & Mol Med, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Dept Surg & Physiol, Milwaukee, WI 53226 USA
[3] Med Coll Wisconsin, Endocrinol Res M4150,8701 Watertown Plank Rd, Milwaukee, WI 53226 USA
来源：
JOURNAL OF THE ENDOCRINE SOCIETY | 2024年 / 8卷 / 03期
关键词：
Cushing syndrome; nonneoplastic hypercortisolism; chronic kidney disease; end-stage renal disease; late-night salivary cortisol; urine free cortisol; SALIVARY CORTISOL;
D O I：
10.1210/jendso/bvae007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] ACTH following overnight dexamethasone suppression can be used in the verification of autonomous cortisol secretion in patients with adrenal incidentalomas
    Puvaneswaralingam, Shobitha
    Kjellbom, Albin
    Lindgren, Ola
    Londahl, Magnus
    Olsen, Henrik
    CLINICAL ENDOCRINOLOGY, 2021, 94 (02) : 168 - 175
  • [22] Low-dose ferrous bisglycinate chelate supplementation in chronic kidney disease and hemodialysis patients
    Hsu, Cheng-Yi
    Chen, Jui-Ching
    Tsai, Yu-Cheng
    Chen, Tzen-Wen
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2022, 85 (05) : 566 - 570
  • [23] Effects of low-dose niacin on dyslipidemia and serum phosphorus in patients with chronic kidney disease
    Kang, Hyo Jin
    Kim, Do Kyong
    Lee, Su Mi
    Kim, Kyung Han
    Han, Seung Hee
    Kim, Ki Hyun
    Kim, Seong Eun
    Son, Young Ki
    An, Won Suk
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2013, 32 (01) : 21 - 26
  • [24] Does low-dose spironolactone increase cardiovascular protection in patients with chronic kidney disease?
    Garcia-Carro, Clara
    Sarafidis, Pantelis
    CLINICAL KIDNEY JOURNAL, 2025, 18 (03)
  • [25] The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome
    Tsagarakis, S
    Kokkoris, P
    Roboti, C
    Malagari, C
    Kaskarelis, J
    Vlassopoulou, V
    Alevizaki, C
    Thalassinos, N
    CLINICAL ENDOCRINOLOGY, 1998, 48 (05) : 627 - 633
  • [26] Influence of dental restoration under general anaesthesia on the low-dose dexamethasone suppression test in dogs
    Hoffrogge, Stefanie
    Schmicke, Marion
    Mischke, Reinhard
    RESEARCH IN VETERINARY SCIENCE, 2020, 129 : 117 - 119
  • [27] The discriminatory value of the low-dose dexamethasone suppression test in the investigation of paediatric Cushing's syndrome
    Dias, R
    Storr, HL
    Perry, LA
    Isidori, AM
    Grossman, AB
    Savage, MO
    HORMONE RESEARCH, 2006, 65 (03) : 159 - 162
  • [28] Extended low-dose dexamethasone suppression test for diagnosis of atypical Cushing's syndrome in dogs
    Fowler, K. M.
    Frank, L. A.
    Morandi, F.
    Whittemore, J. C.
    DOMESTIC ANIMAL ENDOCRINOLOGY, 2017, 60 : 25 - 30
  • [29] Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation
    F. Ceccato
    C. Artusi
    M. Barbot
    L. Lizzul
    S. Pinelli
    G. Costantini
    S. Niero
    G. Antonelli
    M. Plebani
    C. Scaroni
    Journal of Endocrinological Investigation, 2020, 43 : 1105 - 1113
  • [30] Evaluation of individual low-dose dexamethasone suppression test patterns in naturally occurring hyperadrenocorticism in dogs
    Bennaim, Michael
    Shiel, Robert E.
    Forde, Christopher
    Mooney, Carmel T.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2018, 32 (03) : 967 - 977
12345